Avian Metapneumovirus Subtype A&B NP antibody and antigen (recombinant protein)

Diagnostic anti-Avian Metapneumovirus Subtype A&B NP antibodies pairs and antigen for animal health (animal Avian/Bird/Poultry infectious disease Avian metapneumovirus infection) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Avian/Bird/Poultry disease testing products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-VT-P196-Tg001-Ag01 Recombinant Avian Metapneumovirus Subtype A&B NP protein $3090.00
GMP-VT-P196-Tg001-Ab01 Anti-Avian Metapneumovirus Subtype A&B NP mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P196-Tg001-Ab02 Anti-Avian Metapneumovirus Subtype A&B NP mouse monoclonal antibody (mAb) $3090.00
GMP-VT-P196-Tg001-Ab03 Anti-Avian Metapneumovirus Subtype A&B NP human monoclonal antibody (mAb) $3090.00
GMP-VT-P196-Tg001-Ab04 Anti-Avian Metapneumovirus Subtype A&B NP human monoclonal antibody (mAb) $3090.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. GMP-VT-P196-Tg001-Ag01
Product Name Recombinant Avian Metapneumovirus Subtype A&B NP protein
Pathogen Avian Metapneumovirus Subtype A&B
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation Anti-Avian Metapneumovirus Subtype A&B NP antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Avian Metapneumovirus Subtype A&B level test of animal Avian/Bird/Poultry infectious disease with Avian metapneumovirus infection.
Tag His
Product description Recombinant Avian Metapneumovirus Subtype A&B NP proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P196-Tg001-Ab01,GMP-VT-P196-Tg001-Ab02
Pathogen Avian Metapneumovirus Subtype A&B
Product Name Anti-Avian Metapneumovirus Subtype A&B NP mouse monoclonal antibody (mAb)
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Recombinant Avian Metapneumovirus Subtype A&B NP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Avian Metapneumovirus Subtype A&B antibodies in Avian Metapneumovirus Subtype A&B level test of animal Avian/Bird/Poultry infectious disease with Avian metapneumovirus infection.
Product description Anti-Avian Metapneumovirus Subtype A&B NP mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Avian Metapneumovirus Subtype A&B antibodies.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. GMP-VT-P196-Tg001-Ab03,GMP-VT-P196-Tg001-Ab04
Pathogen Avian Metapneumovirus Subtype A&B
Product Name Anti-Avian Metapneumovirus Subtype A&B NP human monoclonal antibody (mAb)
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Recombinant Avian Metapneumovirus Subtype A&B NP antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Avian Metapneumovirus Subtype A&B antibodies in Avian Metapneumovirus Subtype A&B level test of animal Avian/Bird/Poultry infectious disease with Avian metapneumovirus infection.
Product description Anti-Avian Metapneumovirus Subtype A&B NP mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Purity Purity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Pathogen Information


    Avian Metapneumovirus Subtype A and B (AMPV-A & AMPV-B): A Comprehensive Examination

    Avian Metapneumovirus, comprising Subtypes A and B (AMPV-A & AMPV-B), stands as a significant pathogenic entity within the Pneumoviridae family. This diverse family of viruses, characterized by a single-stranded, negative-sense RNA genome, encompasses several human and avian pathogens. Among them, AMPV-A and AMPV-B have emerged as notorious culprits in avian respiratory diseases, causing substantial economic losses in the poultry industry worldwide.

    Structural Insights:

    At the heart of AMPV-A and AMPV-B's pathogenicity lie their intricate genetic structures. The viral genome encodes essential proteins vital for the viral life cycle. The Fusion (F) protein, a transmembrane glycoprotein, plays a pivotal role in facilitating membrane fusion between the viral envelope and host cell membranes, enabling viral entry into the host cell. Another critical glycoprotein, the Attachment (G) protein, is responsible for binding the virus to host cell receptors, initiating the infection process. The Nucleoprotein (N) encapsulates the viral RNA genome, safeguarding it during various stages of the replication cycle. Additionally, the Phosphoprotein (P) plays a regulatory role in RNA synthesis, ensuring precise replication and transcription processes. Lastly, the Large Polymerase (L) protein serves as the RNA-dependent RNA polymerase, orchestrating the replication and transcription of the viral genome.

    Host Range and Disease Impact:

    AMPV-A and AMPV-B exhibit a broad host range, predominantly affecting avian species such as chickens and turkeys. In infected poultry, AMPV-A manifests as Avian Rhinotracheitis (ART), characterized by respiratory distress, nasal discharge, and a drop in egg production. On the other front, AMPV-B leads to Swollen Head Syndrome (SHS) and respiratory complications, severely compromising the overall health and productivity of affected birds. These diseases not only cause direct morbidity and mortality but also significantly impair flock growth rates, feed conversion, and egg quality, posing substantial challenges to the poultry industry.

    Diagnostic Approaches:

    Rapid and accurate diagnosis of AMPV-A and AMPV-B infections is imperative for implementing timely control measures. Molecular diagnostic techniques have proven invaluable in this regard. Polymerase Chain Reaction (PCR), a widely employed method, amplifies specific regions of the viral genome, such as the F or G genes, enabling sensitive and specific detection of the viral genetic material. Reverse Transcription PCR (RT-PCR) further refines this approach, specifically targeting RNA molecules, thus allowing for the identification and quantification of viral RNA. Real-Time PCR (qPCR), an advancement in PCR technology, offers enhanced sensitivity and enables quantitative assessment of viral RNA concentration, aiding in disease monitoring and surveillance efforts.

    Complementing these molecular methods, serological techniques such as Enzyme-Linked Immunosorbent Assay (ELISA) play a pivotal role in detecting antibodies specific to AMPV-A and AMPV-B. By identifying the presence of these antibodies in avian hosts, ELISA tests provide valuable insights into the prevalence of the virus within poultry populations, guiding vaccination strategies and biosecurity measures.

    In conclusion, the comprehensive understanding of AMPV-A and AMPV-B, from their genetic structure to their impact on avian health, is essential for the effective management of avian respiratory diseases. Accurate diagnostic methodologies empower veterinarians and researchers to swiftly identify infections, allowing for timely interventions to curb the spread of these pathogens. Continued research and vigilance are vital to stay ahead of the evolutionary adaptations of AMPV-A and AMPV-B, ensuring the sustained health and productivity of avian populations globally.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.